Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion description "[The cysteine replacement of the highly conserved Y367 residue in fibroblast growth factor receptor 4 or the Q26X nonsense mutation in the tumor-suppressor kinase CSK are examples, and may contribute to cell line-specific signaling characteristics and tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion evidence source_evidence_literature NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion SIO_000772 18056464 NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion wasDerivedFrom befree-20150227 NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_assertion wasGeneratedBy ECO_0000203 NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP332555.RAH_-i92wBy2jp0U1QqUy5gNj3lCfj2n4vtT0dagN3MLU130_provenance.